- Home
- ALAR vs XBIT Comparison
ALAR vs XBIT Comparison
Compare ALAR & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALAR
- XBIT
- Stock Information
- Founded
- ALAR 2013
- XBIT 2005
- Country
- ALAR Israel
- XBIT United States
- Employees
- ALAR N/A
- XBIT N/A
- Industry
- ALAR Computer Software: Prepackaged Software
- XBIT Pharmaceuticals and Biotechnology
- Sector
- ALAR Technology
- XBIT Health Care
- Exchange
- ALAR Nasdaq
- XBIT Nasdaq
- Market Cap
- ALAR 85.8M
- XBIT 86.3M
- IPO Year
- ALAR 2018
- XBIT 2015
- Fundamental
- Price
- ALAR $11.96
- XBIT $2.85
- Analyst Decision
- ALAR Strong Buy
- XBIT
- Analyst Count
- ALAR 1
- XBIT 0
- Target Price
- ALAR $15.00
- XBIT N/A
- AVG Volume (30 Days)
- ALAR 101.4K
- XBIT 50.1K
- Earning Date
- ALAR 08-25-2025
- XBIT 08-11-2025
- Dividend Yield
- ALAR N/A
- XBIT N/A
- EPS Growth
- ALAR N/A
- XBIT N/A
- EPS
- ALAR 0.07
- XBIT N/A
- Revenue
- ALAR $30,581,000.00
- XBIT N/A
- Revenue This Year
- ALAR N/A
- XBIT N/A
- Revenue Next Year
- ALAR $12.28
- XBIT N/A
- P/E Ratio
- ALAR $18.45
- XBIT N/A
- Revenue Growth
- ALAR 4.67
- XBIT N/A
- 52 Week Low
- ALAR $5.45
- XBIT $2.50
- 52 Week High
- ALAR $28.43
- XBIT $8.32
- Technical
- Relative Strength Index (RSI)
- ALAR 48.84
- XBIT 47.38
- Support Level
- ALAR $11.81
- XBIT $2.84
- Resistance Level
- ALAR $12.45
- XBIT $3.18
- Average True Range (ATR)
- ALAR 0.56
- XBIT 0.17
- MACD
- ALAR -0.18
- XBIT -0.02
- Stochastic Oscillator
- ALAR 36.42
- XBIT 19.30
About ALAR Alarum Technologies Ltd.
Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.